The win ratio for evaluating edoxaban vs dalteparin for cancer-associated venous thromboembolism: an analysis of the randomized Hokusai Venous Thromboembolism Cancer trial

We observed no significant difference between edoxaban and dalteparin for the treatment of cancer-associated VTE when using the win ratio approach with a hierarchy of 10 prioritized outcomes.

Authors

Institutions

Publication Details

Journal
Journal of Thrombosis and Haemostasis
Published
2025-12-19
DOI
https://doi.org/10.1016/j.jtha.2025.11.024
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The win ratio for evaluating edoxaban vs dalteparin for cancer-associated venous thromboembolism: an analysis of the randomized Hokusai Venous Thromboembolism Cancer trial

Björn Redfors, Luuk J.J. Scheres, Marcello Di Nisio, Kristen M. Sanfilippo et al.
Journal of Thrombosis and Haemostasis
Venous Thromboembolism Diagnosis and Management
article

The win ratio for evaluating edoxaban vs dalteparin for cancer-associated venous thromboembolism: an analysis of the randomized Hokusai Venous Thromboembolism Cancer trial

Björn Redfors, Luuk J.J. Scheres, Marcello Di Nisio, Kristen M. Sanfilippo, Peter Verhamme, William F. McIntyre, Patrick M. Bossuyt, Nick van Es, Renato D. Lópes, Deborah M. Siegal, Jeffrey Ian Weitz, Marc Carrier, Annelise Segers, Michael Grosso, Harry Büller
article en

Abstract

We observed no significant difference between edoxaban and dalteparin for the treatment of cancer-associated VTE when using the win ratio approach with a hierarchy of 10 prioritized outcomes.

Journal of Thrombosis and HaemostasisVol. 24(3)
Radboud University Nijmegen (NL), University of Ottawa (CA), Cornell University (US), Leiden University Medical Center (NL), Ottawa Hospital (CA), Sahlgrenska University Hospital (SE), Population Health Research Institute (CA), Radboud University Medical Center (NL), University of Chieti-Pescara (IT), St. Louis VA Medical Center (US), Amsterdam Neuroscience (NL), Health Action International (NL), Duke Medical Center (US), Amsterdam University Medical Centers (NL), Thrombosis and Atherosclerosis Research Institute (CA), Daiichi Sankyo (United States) (US), Saint Louis University (US), University of Amsterdam (NL), KU Leuven (BE)
Openalex Percentile: Top 37%
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.